ESR Essentials: diagnosis of hepatocellular carcinoma—practice recommendations by ESGAR
European Radiology · 21.02.2024 · 34 (4) · 2127-2139
DOI: 10.1007/s00330-024-10606-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Radiology, online erschienen am 21.02.2024. Verfasst von Roberto Cannella und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Radiology - Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Palermo, Italy. rob.cannella89…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Palermo.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the most common primary hepatic malignancy and a leading cause of cancer related death worldwide. Current guidelines for the noninvasive diagnosis of HCC are provided by the European Association for the Study of the Liver (EASL), the American Association for the Study of Liver Diseases (AASLD) which endorsed the Liver Imaging Reporting and Data System (LI-RADS) algorithm, the Korean Liver Cancer Association-National Cancer Center (KLCA-NCC), and the Asian-Pacific Association for the Study of the Liver (APASL). These allow the diagnosis of HCC in high-risk patients in the presence of typical imaging features on contrast-enhanced CT, MRI, or contrast-enhanced ultrasound. Size, non-rim arterial phase hyperenhancement, non-peripheral washout, enhancing capsule, and growth are major imaging features and they should be combined for the diagnosis of HCC. This article provides concise and relevant practice recommendations aimed at general radiologist audience, summarizing the best practice and informing on the essential imaging criteria for the diagnosis of HCC, while also discussing the high-risk population criteria, imaging modalities, and imaging features according to the current guidelines. Key Points • Noninvasive diagnosis of hepatocellular carcinoma (HCC) can be provided only in patients at high risk. • Contrast-enhanced CT or MRI are the first-line imaging exams for the diagnosis of HCC. • Major imaging features should be combined to provide the diagnosis of definitive HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Radiology - Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Palermo, Italy. rob.cannella89@gmail.com.
- Department of Radiology, Saint Joseph and Marie Lannelongue Hospitals, Paris, France.
- Section of Radiology - Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Palermo, Italy.
Förderung
- Università degli Studi di Palermo
Zitieren
APA
Cannella, R., Zins, M., & Brancatelli, G. (2024). ESR Essentials: diagnosis of hepatocellular carcinoma—practice recommendations by ESGAR. European Radiology, 34(4), 2127-2139. https://doi.org/10.1007/s00330-024-10606-w
Vancouver
Cannella R, Zins M, Brancatelli G. ESR Essentials: diagnosis of hepatocellular carcinoma—practice recommendations by ESGAR. European Radiology. 2024;34(4):2127-2139. doi:10.1007/s00330-024-10606-w
BibTeX
@article{Cannella2024,
author = {Cannella, Roberto and Zins, Marc and Brancatelli, Giuseppe},
title = {ESR Essentials: diagnosis of hepatocellular carcinoma—practice recommendations by ESGAR},
journal = {European Radiology},
year = {2024},
volume = {34},
number = {4},
pages = {2127--2139},
doi = {10.1007/s00330-024-10606-w}
}
EUVIMED